SBI Biotech Co., Ltd.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Subsidiary
- Established
- 2001-03-30
- Employees
- -
- Market Cap
- -
- Website
- http://www.sbibiotech.jp
A Phase I Study of GNKG168 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)
- First Posted Date
- 2009-12-18
- Last Posted Date
- 2014-12-23
- Lead Sponsor
- SBI Biotech Co., Ltd.
- Target Recruit Count
- 18
- Registration Number
- NCT01035216
- Locations
- 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
🇺🇸Cornell University, New York, New York, United States
🇺🇸Oregon Health & Sciences University, Portland, Oregon, United States
© Copyright 2025. All Rights Reserved by MedPath